title: Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.
abstract: Some investigators have speculated that structural brain alterations observed in some psychiatric patients might be related to increased limbic-hypothalamic-pituitary-adrenal axis (LHPA) activity. To explore this hypothesis, we prospectively studied 166 research volunteers (19 patients with research diagnostic criteria (RDC) major depression, 9 patients with RDC bipolar depression, 45 patients with RDC schizophrenia, and 94 RDC normal controls), examining the relationship between magnetic resonance image-determined ventricular-to-brain ratio (VBR) and indices of LHPA axis function (cerebrospinal fluid (CSF) corticotropin-releasing factor (CRF), CSF adrenocorticotropic hormone (ACTH), and 24-hour urinary-free cortisol secretion). We observed no significant differences in mean VBR among the three patient groups and the normal control volunteers. Of the indices of LHPA activity, only CSF CRF concentrations distinguished the four subject groups, with CSF CRF being significantly elevated in the more severely depressed major depression patients. Indices of LHPA activity were not significantly correlated with VBR in any of the three patient groups or in the normal volunteers. These preliminary results suggest that VBR is not highly associated with alterations in LHPA activity, at least as determined cross-sectionally. Further longitudinal studies with reference to diagnostic subtypes, severity, symptom profiles, and more specific neuroanatomic regions may allow the elucidation of possible relationships between LHPA pathology and structural brain alterations.
authors.affiliation: Department of Psychiatry, Emory University, Atlanta, Georgia 30322.
authors.forename: S C
authors.initials: SC
authors.lastname: Risch
authors.forename: R J
authors.initials: RJ
authors.lastname: Lewine
authors.forename: N H
authors.initials: NH
authors.lastname: Kalin
authors.forename: R D
authors.initials: RD
authors.lastname: Jewart
authors.forename: E D
authors.initials: ED
authors.lastname: Risby
authors.forename: J M
authors.initials: JM
authors.lastname: Caudle
authors.forename: M
authors.initials: M
authors.lastname: Stipetic
authors.forename: J
authors.initials: J
authors.lastname: Turner
authors.forename: M B
authors.initials: MB
authors.lastname: Eccard
authors.forename: W E
authors.initials: WE
authors.lastname: Pollard
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000134:cerebrospinal fluid; D000328:Adult; D001921:Brain / Q000473:pathology*; D001923:Brain Chemistry / Q000502:physiology; D002552:Cerebral Ventricles / Q000473:pathology*; D003346:Corticotropin-Releasing Hormone / Q000134:cerebrospinal fluid; D003866:Depressive Disorder / Q000134:cerebrospinal fluid / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000134:cerebrospinal fluid; D007030:Hypothalamo-Hypophyseal System / Q000473:pathology*; D008032:Limbic System / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D019964:Mood Disorders / Q000134:cerebrospinal fluid / Q000473:pathology*; D010913:Pituitary-Adrenal System / Q000473:pathology*; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000473:pathology*
chemical_list: D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone